(Q66024900)

English

Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

GHLIQUID-1516: A 104-week, Multi-centre, Randomised, Double-blind, Parallel-group, no Treatment Controlled (Open-label) Trial Investigating the Efficacy and Safety of Two Doses of NN-220 in Subjects With Short Stature Born Small for Gestational Age / GHLIQUID-1517: A Long-term, Multi-centre, Randomised, Controlled, Double-blind, Parallel-group Trial, Investigating the Efficacy and Safety of Two Doses of NN-220 in Subjects With Short Stature Born Small for Gestational Age (English)

0 references

country

Japan

0 references

start time

18 August 2004

0 references

end time

29 March 2006

0 references

number of participants

98